estrogen replacement therapy reduces the risk of colorectal cancer

December 1999

There's increasing evidence that estrogen replacement therapy reduces the risk of colorectal cancer.

This benefit started showing up several years ago.

Now it seems that estrogen lowers the risk of colorectal cancer by about a third.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote